Cargando…
β-adrenergic receptor agonist, Compound 49b, inhibits TLR4 signaling pathway in diabetic retina
Diabetic retinopathy has recently become associated with complications similar to chronic inflammatory diseases. While it is clear that tumor necrosis factor- alpha (TNF-α) is increased in diabetes, the role of innate immunity is only recently being investigated. As such, we hypothesized that diabet...
Autores principales: | Berger, Elizabeth A., Carion, Thomas W., Jiang, Youde, Liu, Li, Chahine, Adam, Walker, Robert Jason, Steinle, Jena J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980247/ https://www.ncbi.nlm.nih.gov/pubmed/26888251 http://dx.doi.org/10.1038/icb.2016.21 |
Ejemplares similares
-
A regulatory role for β-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina
por: Shi, Haoshen, et al.
Publicado: (2017) -
β1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo
por: Jiang, Youde, et al.
Publicado: (2014) -
Compound 49b Restores Retinal Thickness and Reduces Degenerate Capillaries in the Rat Retina following Ischemia/Reperfusion
por: Liu, Li, et al.
Publicado: (2016) -
Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice
por: Liu, Li, et al.
Publicado: (2017) -
Compound 49b Regulates ZO-1 and Occludin Levels in Human Retinal Endothelial Cells and in Mouse Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2017)